102 -10 (84) 2025 -M.D. Yusupova, N.M. Normatova - RETINAL SLEEP LAMP: AN INNOVATIVE APPROACH TO TREATING LIGHT SENSITIVITY DISORDERS IN DIABETIC MACULAR EDEMA

RETINAL SLEEP LAMP: AN INNOVATIVE APPROACH TO TREATING LIGHT SENSITIVITY DISORDERS IN DIABETIC MACULAR EDEMA

M.D. Yusupova - Center for the Development of Professional Qualifications of Medical Workers under the Ministry of Health of the Republic of Uzbekistan

N.M. Normatova - Center for the Development of Professional Qualifications of Medical Workers under the Ministry of Health of the Republic of Uzbekistan

Resume

Diabetic macular edema (DMD) is one of the most serious complications of diabetic retinopathy and remains the leading cause of visual impairment in working-age patients in developed countries. According to the International Diabetes Federation, by 2045, the number of people with diabetes will reach 693 million, which will inevitably lead to an increase in the number of patients with diabetic complications of the organ of vision. These processes are accompanied not only by structural changes in the retina but also by significant functional disorders, including decreased light sensitivity and disruption of circadian rhythms.

Keywords: diabetes mellitus, diabetic retinopathy, macular edema, light sensitivity, retinal sleep lamp, dark adaptation

First page

589

Last page

593

For citation:M.D. Yusupova, N.M. Normatova - RETINAL SLEEP LAMP: AN INNOVATIVE APPROACH TO TREATING LIGHT SENSITIVITY DISORDERS IN DIABETIC MACULAR EDEMA//New Day in Medicine 10(84)2025 589-593 https://newdayworldmedicine.com/en/new_day_medicine/10-84-2025

List of References

1. Cheung N., Mitchell P., Wong T.Y. Diabetic retinopathy. The Lancet. 2010;376(9735):124–136.
2. Yau J.W. et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564.
3. Antonetti D.A., Klein R., Gardner T.W. Diabetic retinopathy. N Engl J Med. 2012; 366:1227–1239.
4. Arden G.B., Sivaprasad S. The pathogenesis of early diabetic retinopathy: The roles of retinal hypoxia and dark adaptation. Eye. 2011; 25:1534–1549.
5. Kurihara T., et al. Retinal hypoxia and photoreceptor metabolism in diabetic retinopathy. Prog Retin Eye Res. 2016; 54:1–29.
6. Simó R., Hernández C. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab. 2014;25(1):23–33.
7. Joltikov K.A., et al. Disorganization of retinal inner layers as a biomarker of diabetic retinopathy severity. Ophthalmology. 2018;125(8):1189–1199.
8. Antonetti D.A., Klein R., Gardner T.W. Diabetic retinopathy // New England Journal of Medicine. – 2012. – Vol. 366, № 13. – P. 1227-1239. DOI: 10.1056/NEJMra1005073
9. Yau J.W., Rogers S.L., Kawasaki R., et al. Global prevalence and major risk factors of diabetic retinopathy // Diabetes Care. – 2012. – Vol. 35, № 3. – P. 556-564. DOI: 10.2337/dc11-1909
10. Saeedi P., Petersohn I., Salpea P., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition // Diabetes Research and Clinical Practice. – 2019. – Vol. 157. – P. 107843. DOI: 10.1016/j.diabres.2019.107843
11. Jackson G.R., Barber A.J. Visual dysfunction associated with diabetic retinopathy // Current Diabetes Reports. – 2010. – Vol. 10, № 5. – P. 380-384. DOI: 10.1007/s11892-010-0132-4

    file

    download